Invesco India Contra Fund

A Contra Fund scheme from Invesco Mutual Fund. Figures below are for the Direct · Growth plan (ISIN INF205K01LE4).

NAV ₹165.4300 on 16 November 2026.

Expense ratio

Total expense ratio 0.76% a year for the Direct · Growth plan, as AMFI published it on 29 October 2026: base expense ratio 0.49%, brokerage 0.06%, transaction costs 0.00%, statutory levies including GST 0.21%.

Returns and risk

PeriodReturn a yearVolatilityWorst fallSharpeSortino
1 year1.6%16.0%-16.5%-0.33-0.33
3 years15.6%15.2%-18.6%0.570.52
5 years12.9%14.7%-18.6%0.400.37
10 years17.3%16.3%-36.5%0.630.56

Not ranked in its category: too few comparable funds have the history to rank against.

Largest holdings

Top 10 (October 2026 disclosure). Company shares make up 97.4% of the portfolio.

  1. ICICI Bank Limited — 6.77%
  2. Larsen & Toubro Limited — 4.68%
  3. State Bank of India — 3.33%
  4. Mahindra & Mahindra Limited — 2.85%
  5. Bharti Airtel Limited — 2.70%
  6. Infosys Limited — 2.58%
  7. Cholamandalam Investment and Finance Company Limited — 2.40%
  8. Coforge Limited — 2.29%
  9. The Federal Bank Limited — 2.28%
  10. Apollo Hospitals Enterprise Limited — 2.13%

Plans

Other funds in Contra Fund

All 6 funds in Contra Fund · Compare this fund with another

Past returns are history, not a forecast. XIRRO describes funds and portfolios; it is information, not investment advice.